Participated · Equity · May 2025

Hub is a global insurance brokerage and financial services firm focused on servicing middle and upper‑middle market clients. Its core offerings include industry- and product-specialized risk management, brokerage services, proprietary products, digital solutions and new distribution channels. The company emphasizes cross-selling, seamless M&A integration, talent acquisition, and strong net new business performance to drive organic growth. Recurring investments reflect investor confidence in Hub's scale, profitability, and consistent organic revenue growth. Annual revenue increased over fourfold from $1.1 billion in 2013 to $4.8 billion in 2024. Management holds a significant equity position while Hellman & Friedman retains controlling interest.

Participated · Series B · Sep 2021

TreeFrog Therapeutics develops stem cell–derived cell therapies and a proprietary C‑Stem™ high‑throughput cell encapsulation platform to mass‑produce and differentiate stem cells in industrial bioreactors. The company intends to deploy C‑Stem for clinical‑grade manufacturing and advance a pipeline of cell therapies toward the clinic, and to open technology hubs in Boston and Kobe. TreeFrog plans to use the new funds to scale manufacturing and support clinical development. Since incorporation in November 2018 in Bordeaux, France, the team has grown to more than 50 employees and moved into a 13,000 sq. ft. production facility in June 2020. The company previously raised over €10M ($11.7M) in 2019 and joined the FrenchTech120 in January 2020. Current leadership changes tied to the round include the appointment of Frederic Desdouits as CEO and the creation of a U.S. subsidiary to be led by co‑founder Kevin Alessandri. TreeFrog Therapeutics develops C‑Stem, a proprietary 3D cell culture system designed to enable mass production of pluripotent stem cells while preserving genomic integrity. C‑Stem is compatible with conventional bioreactors and aims to lower cell‑therapy production costs and accelerate bioproduction for diseases such as Parkinson’s, type 1 diabetes, and heart failure. The company says C‑Stem will turn into a bioproduction platform to supply stem cells and differentiated therapeutic cells and targets first clinical‑grade batches by 2021. TreeFrog has secured intellectual property, closed a Series A round, and established operations and governance. The recent funding will be used to attain cGMP certification (a prerequisite for FDA approval), extend production capacity, and further develop the C‑Stem platform. Management is recruiting executives to lead cGMP efforts and scale manufacturing. TreeFrog Therapeutics, incorporated in November 2018 and based in Bordeaux, France, has developed C-Stem™, a proprietary 3D stem cell culture platform intended to provide scalable, higher-quality therapeutic cells while reducing treatment costs. The company aims to apply the technology across multiple indications including Huntington’s disease, Parkinson’s disease, heart failure, diabetes and NASH through proprietary and collaborative research programs. TreeFrog plans to transition C-Stem™ to cGMP standards by 2021 and targets a first-in-man clinical trial in 2024. Management is led by Kevin Alessandri (CEO & CTO) and Maxime Feyeux (President, CSO). The company pursues strategic partnerships and co-developments with pharma and cell therapy initiatives to accelerate clinical development and facilitate market access. Financially, TreeFrog completed a Series A financing and obtained non-dilutive public support to advance its development and manufacturing plans.

Led · Equity · Sep 2020

Pure Gym is a budget gym operator that runs a network of low-cost fitness clubs across the UK and Europe. Its core offering is physical gym access, and it has implemented TrainSafe protocols and equivalent COVID-19-safe arrangements to reopen its estate. The company said its second-quarter performance was significantly impacted by gym closures during the UK coronavirus lockdown, though like-for-like member volumes and gym visits have been encouraging since reopening. To bolster its balance sheet it secured a £100m equity injection from shareholders Leonard Green Partners and boosted its Revolving Credit Facility by £50m, bringing total liquidity to £297m. Management says the funds are intended to provide a cash buffer against local or national lockdowns and to support a return to a growth strategy. CEO Humphrey Cobbold credited the team with preserving cash, refitting gyms for safety, and re-earning member trust.

Participated · Equity · Jun 2010

Authentic Brands Group operates a brand development, marketing and entertainment platform that connects iconic brands with partners, operators, distributors and retailers. The company acquires and manages consumer and lifestyle brands and has expanded into media, outdoor, events, experiences and studios (Authentic Studios). Recent strategic activity includes acquisitions and deals involving Reebok, Ted Baker, Vince, Hunter and a definitive agreement to purchase Boardriders. Authentic intends to continue worldwide expansion and to accelerate its playbook for building brand value through partnerships and content. The platform’s portfolio generates more than $25 billion in global annual retail sales and has a retail footprint across 150 countries with 10,800+ freestanding stores and shop-in-shops and 380,000 points of sale. Authentic was founded in 2010 and is headquartered in New York City. Authentic Brands Group is a brand development, marketing and entertainment company founded in 2010 and based in New York City. ABG owns a portfolio of over 50 brands that generate close to USD $10 billion in annual worldwide revenue across more than 70 countries. Its portfolio spans the luxury, specialty and mid‑tier retail channels in both e‑commerce and brick‑and‑mortar. The company’s holdings are diversified across lifestyle, sports, celebrity, entertainment and media sectors and include icons such as Marilyn Monroe, Elvis Presley, Muhammad Ali, Shaquille O’Neal, Nautica, Aéropostale, Juicy Couture and recently acquired Sports Illustrated. ABG focuses on brand development, marketing and entertainment activities to monetize and grow its assets. Management is led by founder, chairman and CEO James Salter with President and CMO Nick Woodhouse. Authentic Brands Group (ABG) is a New York-based brand development, marketing and entertainment company founded in 2010 by Jamie Salter. ABG owns a broad portfolio of lifestyle, sports and celebrity brands, including Marilyn Monroe, Elvis Presley, Shaquille O’Neal, Juicy Couture, Aéropostale, Jones New York, Neil Lane, Frye, Spyder, Prince and Herve Leger. The company says its brands generate over $5 billion in annual retail sales. ABG focuses on acquiring, developing and marketing iconic and world‑renowned brands across categories. The company intends to continue growing internationally through new brand partnerships and acquisitions. ABG plans to expand into new categories, innovate across digital platforms and broaden its global footprint with a key focus on the Chinese market. Authentic Brands Group operates a brand licensing and management business that acquires and manages consumer brands across apparel, sporting goods, action sports, home, celebrity, entertainment and consumer electronics. The company provides brand-management services, including a celebrity-brand division that manages the Bob Marley family’s brand. It has a track record—through founder James Salter and partner Kenneth Finkelstein—of acquiring and operating brands such as Polaroid, The Sharper Image, Ellen Tracy, Halston, Ride Snowboards and Airwalk. The business also leverages celebrity partnerships (examples cited include Sarah Jessica Parker at Halston and Lady Gaga at Polaroid) to boost brand recognition. Authentic Brands Group completed a USD250m equity capital raise to fund growth of its brand acquisition and management strategy. The capital will be used to acquire and expand a global portfolio of consumer and celebrity brands.

Led · Equity · Jan 2010

AerSale supplies aftermarket aircraft, engines and component parts to airlines, leasing companies and OEM/MRO service providers. The company completed an initial $250M equity raise with Green Equity Investors V, an affiliate of Leonard Green & Partners. Management said the partnership will allow AerSale to focus on acquiring, leasing and redistributing products to the aviation industry. AerSale plans to acquire over $1 billion of aviation assets during the next five years. Leadership frames the company as a well-capitalized participant positioned to provide cost-effective aftermarket flight equipment and high customer satisfaction. The company aims to assist airlines with fleet transitions through sale-leaseback transactions or outright purchase and remarketing of aircraft, engines and parts inventories.